Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
Rheumatol Int
    April 2024
  1. PUROHIT R, Bhaskar N, Jehu T, Camargo Macias K, et al
    Patient-reported outcomes of curcumin supplementation in rheumatoid arthritis and psoriatic arthritis: a cross-sectional survey.
    Rheumatol Int. 2024 Apr 16. doi: 10.1007/s00296-024-05577.
    >> Share

  2. LINDGREN LH, de Thurah A, Thomsen T, Hetland ML, et al
    Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis-a survey based cross-sectional study.
    Rheumatol Int. 2024 Apr 2. doi: 10.1007/s00296-024-05553.
    >> Share

  3. FEDORCHENKO Y, Mahmudov K, Abenov Z, Zimba O, et al
    Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs.
    Rheumatol Int. 2024;44:583-591.
    >> Share

  4. ASMAR S, Messaykeh J, Hilal N, Rida MA, et al
    Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey.
    Rheumatol Int. 2024;44:725-736.
    >> Share

    March 2024
  5. GRANT WB
    The present understanding of the effects of dietary red meat and the Mediterranean diet on rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 27. doi: 10.1007/s00296-024-05587.
    >> Share

  6. KALETA K, Krupa J, Suchy W, Sopel A, et al
    Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 24. doi: 10.1007/s00296-024-05556.
    >> Share

  7. BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
    Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage.
    Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
    >> Share

  8. SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
    Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
    Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
    >> Share

  9. LARKIN L, McKenna S, Pyne T, Comerford P, et al
    Promoting physical activity in rheumatoid arthritis through a physiotherapist led behaviour change-based intervention (PIPPRA): a feasibility randomised trial.
    Rheumatol Int. 2024 Mar 4. doi: 10.1007/s00296-024-05544.
    >> Share

  10. DURUOZ MT, Nas K, Kasman SA, Oz N, et al
    Validity and reliability of the Duruoz Hand Index in patients with psoriatic arthritis.
    Rheumatol Int. 2024;44:535-542.
    >> Share

  11. COSKUN BN, Yagiz B, Ocakoglu G, Dalkilic E, et al
    Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use.
    Rheumatol Int. 2024;44:509-515.
    >> Share

  12. COX N, Hawarden A, Bajpai R, Farooq S, et al
    The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol.
    Rheumatol Int. 2024;44:435-440.
    >> Share

  13. KAMINSKI M, Hrycaj P
    Celebrities influence on rheumatic diseases interest: a Google Trends analysis.
    Rheumatol Int. 2024;44:517-521.
    >> Share

    February 2024
  14. SHARMA P, Brown S, Sokoya EM
    Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
    Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
    >> Share

    January 2024
  15. SCHAPINK L, den Broeder N, den Broeder AA, Verhoef LM, et al
    Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2024 Jan 29. doi: 10.1007/s00296-023-05524.
    >> Share

  16. COUREL-IBANEZ J, Vetrovsky T, Ruzickova N, Maranon C, et al
    Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.
    Rheumatol Int. 2024 Jan 5. doi: 10.1007/s00296-023-05507.
    >> Share

  17. MORALIYSKA R, Georgiev T, Bogdanova-Petrova S, Shivacheva T, et al
    Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey.
    Rheumatol Int. 2024;44:165-172.
    >> Share

    December 2023
  18. DURUOZ MT, Ataman S, Bodur H, Cay HF, et al
    Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Rheumatol Int. 2023 Dec 29. doi: 10.1007/s00296-023-05515.
    >> Share

  19. DUBEY S, Woodhead F
    Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
    Rheumatol Int. 2023 Dec 12. doi: 10.1007/s00296-023-05505.
    >> Share

    November 2023
  20. TEUWEN MMH, Vlieland TPMV, van Weely SFE, Schoones JW, et al
    Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.
    Rheumatol Int. 2023 Nov 30. doi: 10.1007/s00296-023-05502.
    >> Share

  21. TEUWEN MMH, van Weely SFE, Vliet Vlieland TPM, Douw T, et al
    Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study.
    Rheumatol Int. 2023 Nov 25. doi: 10.1007/s00296-023-05487.
    >> Share

  22. MIHAYLOVA V, Kazakova M, Batalov Z, Karalilova R, et al
    JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2023 Nov 20. doi: 10.1007/s00296-023-05501.
    >> Share

  23. DE FIGUEIREDO LQ, de Andrade Lopes FO, Franco AS, Giardini HAM, et al
    Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2023 Nov 4. doi: 10.1007/s00296-023-05494.
    >> Share

  24. BEKARYSSOVA D, Yessirkepov M, Mahmudov K
    Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019-2021 data.
    Rheumatol Int. 2023;43:2057-2064.
    >> Share

  25. MAYER M, Martinic M, Reihl-Crnogaj M, Anic B, et al
    The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study.
    Rheumatol Int. 2023;43:2031-2036.
    >> Share

    October 2023
  26. COSKUN BENLIDAYI I
    Exercise therapy for improving cardiovascular health in rheumatoid arthritis.
    Rheumatol Int. 2023 Oct 31. doi: 10.1007/s00296-023-05492.
    >> Share

  27. KOUNATIDIS DC, Papadimitropoulos V, Avramidis K, Plenga E, et al
    Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review.
    Rheumatol Int. 2023 Oct 18. doi: 10.1007/s00296-023-05483.
    >> Share

  28. FLOURI I, Goutakoli P, Repa A, Bertsias A, et al
    Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
    Rheumatol Int. 2023 Oct 10. doi: 10.1007/s00296-023-05455.
    >> Share

  29. THOMSEN T, Aadahl M, Hetland ML, Esbensen BA, et al
    Physical activity guidance in the rheumatology clinic-what matters for patients with rheumatoid arthritis? A qualitative study.
    Rheumatol Int. 2023 Oct 3. doi: 10.1007/s00296-023-05466.
    >> Share

  30. VAN SLINGERLAND K, de Jong PHP, Dolhain RJEM, Pasma A, et al
    The effect of a goal-setting strategy with integrated feedback on goal attainment in inflammatory arthritis patients: a mixed method study.
    Rheumatol Int. 2023;43:1897-1904.
    >> Share

    September 2023
  31. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis.
    Rheumatol Int. 2023 Sep 30. doi: 10.1007/s00296-023-05458.
    >> Share

  32. SULLI A, Clini P, Bruzzone G, Signori A, et al
    An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
    Rheumatol Int. 2023 Sep 13. doi: 10.1007/s00296-023-05444.
    >> Share

  33. AMEZCUA-GUERRA LM, Carbonell-Bobadilla N, Soto-Fajardo C, Vargas A, et al
    Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis.
    Rheumatol Int. 2023 Sep 11. doi: 10.1007/s00296-023-05445.
    >> Share

    August 2023
  34. BHAT SS, Ahmed S, Reji R, Mehta P, et al
    Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.
    Rheumatol Int. 2023 Aug 31. doi: 10.1007/s00296-023-05417.
    >> Share

  35. AL-MAINI M, Maindarkar M, Kitas GD, Khanna NN, et al
    Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a narrative review.
    Rheumatol Int. 2023 Aug 30. doi: 10.1007/s00296-023-05415.
    >> Share

  36. MATHIEU S, Lambert C, Fayet F, Couderc M, et al
    Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients.
    Rheumatol Int. 2023 Aug 11. doi: 10.1007/s00296-023-05405.
    >> Share

    July 2023
  37. SUARDI I, Posio C, Luconi E, Boracchi P, et al
    Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study.
    Rheumatol Int. 2023 Jul 16. doi: 10.1007/s00296-023-05383.
    >> Share

  38. RAAD T, Griffin A, George ES, Larkin L, et al
    Experience and perceptions among rheumatoid arthritis patients following a telehealth-delivered dietary intervention: a qualitative study.
    Rheumatol Int. 2023 Jul 7. doi: 10.1007/s00296-023-05382.
    >> Share

  39. ATHANASSIOU P, Psaltis D, Georgiadis A, Katsifis G, et al
    Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.
    Rheumatol Int. 2023 Jul 5. doi: 10.1007/s00296-023-05376.
    >> Share

  40. GASTELUM-STROZZI A, Flores-Alvarado DE, Pascual-Ramos V, Alvarez-Hernandez E, et al
    The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.
    Rheumatol Int. 2023;43:1253-1264.
    >> Share

  41. FELIS-GIEMZA A, Chmurzynska K, Kolodziejczyk B, Gazda A, et al
    Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
    Rheumatol Int. 2023;43:1307-1311.
    >> Share

  42. CHATTERJEE R, Balakrishnan A, Kharbanda R, Rathore U, et al
    Renal involvement in Sjogren's syndrome: predictors and impact on patient outcomes.
    Rheumatol Int. 2023;43:1297-1306.
    >> Share

    June 2023
  43. WROBEL A, Baranska I, Szklarczyk J, Majda A, et al
    Relationship between perceived stress, stress coping strategies, and clinical status in patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Jun 18. doi: 10.1007/s00296-023-05367.
    >> Share

  44. VICTORIA MA, Lucio VR, Cristina HD
    Patient self-reported instruments for assessing symptoms in rheumatoid arthritis.
    Rheumatol Int. 2023 Jun 15. doi: 10.1007/s00296-023-05355.
    >> Share

  45. GARCIA-SALINAS R, Sanchez-Prado E, Mareco J, Ronald P, et al
    Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations.
    Rheumatol Int. 2023 Jun 3. doi: 10.1007/s00296-023-05349.
    >> Share

  46. ERMEIDIS C, Dimitroulas T, Pourzitaki C, Voulgari PV, et al
    Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey.
    Rheumatol Int. 2023;43:1151-1159.
    >> Share

  47. URHAN E, Urhan AC, Dogan HO, Sahin A, et al
    Assessment of semaphorin 3A and semaphorin 7A levels in primary Sjogren's syndrome.
    Rheumatol Int. 2023;43:1087-1092.
    >> Share

    May 2023
  48. O'BRIEN CM, Kitas GD, Rayner F, Isaacs JD, et al
    Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.
    Rheumatol Int. 2023 May 25. doi: 10.1007/s00296-023-05342.
    >> Share

  49. VENETSANOPOULOU AI, Alamanos Y, Voulgari PV, Drosos AA, et al
    Decline in the incidence of rheumatoid arthritis in north-western Greece in 1980-2019.
    Rheumatol Int. 2023 May 13. doi: 10.1007/s00296-023-05325.
    >> Share

    April 2023
  50. VAN DEN HOEK J, Sobejana M, van Nes F, Metsios G, et al
    Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study.
    Rheumatol Int. 2023 Apr 24. doi: 10.1007/s00296-023-05312.
    >> Share

  51. AUSSERWINKLER M, Neumann HJ, Wernly B
    Rheumatoid arthritis and cardiovascular risk: keep it simple and compassionate.
    Rheumatol Int. 2023 Apr 24. doi: 10.1007/s00296-023-05333.
    >> Share

  52. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    Adherence to biological therapies in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Apr 19. doi: 10.1007/s00296-023-05327.
    >> Share

  53. KODURI GM, Podlasek A, Pattapola S, Zhang J, et al
    Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis.
    Rheumatol Int. 2023 Apr 18. doi: 10.1007/s00296-023-05313.
    >> Share

  54. SEPPEN BF, Wiegel J, Nurmohamed MT, Bos WH, et al
    Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis.
    Rheumatol Int. 2023;43:677-685.
    >> Share

  55. WILK M, Pripp AH, Korkosz M, Haugeberg G, et al
    Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders.
    Rheumatol Int. 2023;43:687-694.
    >> Share

  56. OTON T, Carmona L, Andreu JL
    What do patients on methotrexate need and expect at the clinic? An online patient survey.
    Rheumatol Int. 2023;43:735-741.
    >> Share

  57. MUEHLENSIEPEN F, May S, Hadaschik K, Vuillerme N, et al
    Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.
    Rheumatol Int. 2023;43:695-703.
    >> Share

  58. TANAKA Y, Barrett C, Hirano Y, Ikeda K, et al
    Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinician surveys.
    Rheumatol Int. 2023;43:721-733.
    >> Share

  59. LI Y, Berianu F, Brumble L, Calamia KT, et al
    Synovitis due to Histoplasma capsulatum: a case series and literature review.
    Rheumatol Int. 2023;43:763-769.
    >> Share

  60. OZSOY Z, Ozdemir A, Ekici M, Bilgin E, et al
    Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Rheumatol Int. 2023 Apr 1. doi: 10.1007/s00296-023-05320.
    >> Share

    March 2023
  61. VENETSANOPOULOU AI, Kalpourtzi N, Alamanos Y, Gavana M, et al
    Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO.
    Rheumatol Int. 2023 Mar 31. doi: 10.1007/s00296-023-05316.
    >> Share

  62. DHIR V, Prasad CB, Kumar S, Kaul KK, et al
    Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Mar 18. doi: 10.1007/s00296-023-05305.
    >> Share

  63. LOSINSKA K, Korkosz M, Pripp AH, Haugeberg G, et al
    Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naive to or switched from reference rituximab.
    Rheumatol Int. 2023 Mar 16. doi: 10.1007/s00296-023-05307.
    >> Share

  64. WROBEL A, Szklarczyk J, Baranska I, Majda A, et al
    Association between levels of serotonin, melatonin, cortisol and the clinical condition of patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Mar 13. doi: 10.1007/s00296-023-05296.
    >> Share

  65. PARPERIS K, Achilleos S, Costi E, Vardas M, et al
    Autoimmune rheumatic diseases associated with granulomatous mastitis.
    Rheumatol Int. 2023;43:399-407.
    >> Share

  66. FRADE-SOSA B, Azuaga AB, Ruiz-Esquide V, Gomez-Puerta JA, et al
    Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
    Rheumatol Int. 2023;43:533-536.
    >> Share

  67. CAPKIN E, Yazici A, Karkucak M, Durmaz Y, et al
    Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study.
    Rheumatol Int. 2023;43:523-531.
    >> Share

    February 2023
  68. CHARLES-SCHOEMAN C, Wang J, Shahbazian A, Wilhalme H, et al
    Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Feb 24. doi: 10.1007/s00296-023-05285.
    >> Share

  69. KOSTER F, Bakx PLH, Kok MR, Barreto DL, et al
    Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison.
    Rheumatol Int. 2023 Feb 10. doi: 10.1007/s00296-023-05282.
    >> Share

  70. PARASCHOU V, Partalidou S, Siolos P, Papadopoulou Z, et al
    Prevalence of hearing loss in patients with Sjogren syndrome: a systematic review and meta-analysis.
    Rheumatol Int. 2023;43:233-244.
    >> Share

  71. YOLCU G, Abacar KY, Kenis-Coskun O, Nevsun-Inanc G, et al
    Comparison of cutaneous silent period parameters in patients with primary Sjogren's syndrome with the healthy population and determination of its relationship with clinical parameters.
    Rheumatol Int. 2023;43:355-362.
    >> Share

    January 2023
  72. WIEGEL J, Seppen BF, Nurmohamed MT, Ter Wee MM, et al
    Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Jan 30:1-7. doi: 10.1007/s00296-023-05278.
    >> Share

  73. ELFVING P, Kononoff A, Huhtakangas J, Kautiainen H, et al
    Incidence of seropositive rheumatoid arthritis in population-based studies in Northern Savo, Finland, during 1980-2020.
    Rheumatol Int. 2023 Jan 11:1-8. doi: 10.1007/s00296-022-05268.
    >> Share

  74. GHEITA TA, Raafat HA, El-Bakry SA, Elsaman A, et al
    Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance.
    Rheumatol Int. 2023 Jan 8. doi: 10.1007/s00296-022-05258.
    >> Share

  75. BALAKRISHNAN A, Majumder S, Guleria S, Lawrence A, et al
    Macrophage migration inhibitory factor (MIF) and IgA anti CD74 antibodies in Indian patients with enthesitis-related arthritis category of Juvenile idiopathic arthritis.
    Rheumatol Int. 2023;43:157-162.
    >> Share

    December 2022
  76. KOCYIGIT BF, Sagtaganov Z, Yessirkepov M, Akyol A, et al
    Assessment of complementary and alternative medicine methods in the management of ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia syndrome.
    Rheumatol Int. 2022 Dec 30:1-9. doi: 10.1007/s00296-022-05267.
    >> Share

  77. SANAL-TOPRAK C, Unal-Ulutatar C, Duruoz E, Oz N, et al
    The validity and reliability of the Turkish version of the Arthritis Impact Measurement Scale 2-Short Form (AIMS2-SF) for rheumatoid arthritis.
    Rheumatol Int. 2022 Dec 11. doi: 10.1007/s00296-022-05257.
    >> Share

  78. VIDEM V, Houge IS, Hoff M
    Persons with rheumatoid arthritis have higher barriers to physical activity than controls: a cross-sectional study using the Facilitators and Barriers to Physical Activity Questionnaire (FasBarPAQ).
    Rheumatol Int. 2022 Dec 7. doi: 10.1007/s00296-022-05252.
    >> Share

  79. FEDKOV D, Berghofen A, Weiss C, Peine C, et al
    Efficacy and safety of a mobile app intervention in patients with inflammatory arthritis: a prospective pilot study.
    Rheumatol Int. 2022;42:2177-2190.
    >> Share

  80. CHEN J, He Q, Jiang B, Song W, et al
    Research on primary Sjogren's syndrome in 2004-2021: a Web of Science-based cross-sectional bibliometric analysis.
    Rheumatol Int. 2022;42:2221-2229.
    >> Share

    November 2022
  81. ZOUBI T, Gordon H
    Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity.
    Rheumatol Int. 2022 Nov 30. doi: 10.1007/s00296-022-05245.
    >> Share

  82. SIEMPIS T, Tsakiris C, Anastasia Z, Alexiou GA, et al
    Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Nov 15. pii: 10.1007/s00296-022-05239.
    >> Share

  83. OUARDI NE, Maghraoui AE, Djossou HJ, Taoubane L, et al
    Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study.
    Rheumatol Int. 2022 Nov 5. pii: 10.1007/s00296-022-05237.
    >> Share

  84. NUNE A, Barman B, Sapkota HR, Ish P, et al
    Nanotechnology applications in rheumatology.
    Rheumatol Int. 2022;42:1883-1891.
    >> Share

  85. GASTEIGER C, Scholz U, Petrie KJ, Dalbeth N, et al
    A bio-what? Medical companions' perceptions towards biosimilars and information needs in rheumatology.
    Rheumatol Int. 2022;42:1993-2002.
    >> Share

    October 2022
  86. BLANKEN AB, Raadsen R, Agca R, van Sijl AM, et al
    Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients.
    Rheumatol Int. 2022 Oct 21. pii: 10.1007/s00296-022-05226.
    >> Share

  87. MEDRADO LN, Mendonca MLM, Budib MB, Oliveira-Junior SA, et al
    Effectiveness of aquatic exercise in the treatment of inflammatory arthritis: systematic review.
    Rheumatol Int. 2022;42:1681-1691.
    >> Share

  88. ILGEN U, Karadag O, Emmungil H, Kucuksahin O, et al
    Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
    Rheumatol Int. 2022;42:1797-1806.
    >> Share

    September 2022
  89. REN J, Ding Y, Zhao J, Sun Y, et al
    Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis.
    Rheumatol Int. 2022 Sep 27. pii: 10.1007/s00296-022-05219.
    >> Share

  90. KOSTER F, Lopes Barreto D, Nair SC, Kok MR, et al
    Defining the care delivery value chain and mapping the patient journey in rheumatoid arthritis.
    Rheumatol Int. 2022 Sep 23. pii: 10.1007/s00296-022-05215.
    >> Share

  91. HUANG G, Wu L, Mei Z, Yao D, et al
    Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review.
    Rheumatol Int. 2022 Sep 20. pii: 10.1007/s00296-022-05209.
    >> Share

  92. ATALAR E, Yurdakul FG, Gok K, Guler T, et al
    Motor neuron disease in a patient with overlap syndrome (rheumatoid arthritis; systemic lupus erythematosus, Sjogren's syndrome).
    Rheumatol Int. 2022 Sep 18. pii: 10.1007/s00296-022-05207.
    >> Share

  93. SWIECKA M, Paluch L, Pietruski P, Maslinska M, et al
    Shear wave elastography as a potential additional diagnostic tool in primary Sjogren's syndrome: an observational study.
    Rheumatol Int. 2022;42:1579-1587.
    >> Share

  94. LENDREM DW, Tarn JR, Collins A, Wason J, et al
    Why stratification is important in primary Sjogren's syndrome.
    Rheumatol Int. 2022;42:1661-1662.
    >> Share

    August 2022
  95. JAIN A, Joseph S, James J, James TS, et al
    Delay in diagnosis of rheumatoid arthritis: reasons and trends over a decade.
    Rheumatol Int. 2022 Aug 23. pii: 10.1007/s00296-022-05187.
    >> Share

  96. PARASKEVI VV, Aliki VI, Antigone P, Zoi T, et al
    Orbital myositis in systemic lupus erythematosus: a case-based review.
    Rheumatol Int. 2022;42:1453-1460.
    >> Share

  97. SILVA EV, Almeida LY, Bortoletto KC, Quero IB, et al
    Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjogren's syndrome: a comparative study.
    Rheumatol Int. 2022;42:1411-1421.
    >> Share

  98. AL-EZZI M, Tappuni AR, Khan KS
    The impact of Sjgren's syndrome on the quality of sexual life of female patients in the UK: a controlled analysis.
    Rheumatol Int. 2022;42:1423-1429.
    >> Share

    July 2022
  99. KOUGKAS N, Dara A, Pagkopoulou E, Dimitriadou A, et al
    Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review.
    Rheumatol Int. 2022 Jul 18. pii: 10.1007/s00296-022-05166.
    >> Share

  100. HAN P, Sun C, Zhang Y, Yan J, et al
    Sjogren's syndrome with adult-onset Still's disease: an overlap syndrome?
    Rheumatol Int. 2022;42:1281-1285.
    >> Share

    June 2022
  101. BOYADZHIEVA V, Tachkov K, Stoilov N, Mitov K, et al
    Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies.
    Rheumatol Int. 2022 Jun 27. pii: 10.1007/s00296-022-05163.
    >> Share

  102. INGRAM T, Sengupta R, Standage M, Barnett R, et al
    Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2022 Jun 8. pii: 10.1007/s00296-022-05142.
    >> Share

    May 2022
  103. HOQUE A, Steultjens M, Dickson DM, Hendry GJ, et al
    Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index.
    Rheumatol Int. 2022 May 27. pii: 10.1007/s00296-022-05147.
    >> Share

  104. POPOVA V, Geneva-Popova M, Kraev K, Batalov A, et al
    Assessment of TNF-alpha expression in unstable atherosclerotic plaques, serum IL-6 and TNF-alpha levels in patients with acute coronary syndrome and rheumatoid arthritis.
    Rheumatol Int. 2022 May 26. pii: 10.1007/s00296-022-05113.
    >> Share

  105. ZEKIC T, Benic MS, Radic M
    Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease.
    Rheumatol Int. 2022 May 23. pii: 10.1007/s00296-022-05143.
    >> Share

    April 2022
  106. KARABULUT Y, Gezer HH, Esen S, Esen I, et al
    Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.
    Rheumatol Int. 2022 Apr 25. pii: 10.1007/s00296-022-05132.
    >> Share

  107. PAPPAS DA, Brittle C, Concoff A, Holman AJ, et al
    Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
    Rheumatol Int. 2022 Apr 21. pii: 10.1007/s00296-022-05122.
    >> Share

  108. FEUCHTENBERGER M, Kovacs MS, Eder A, Nigg A, et al
    Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 16. pii: 10.1007/s00296-022-05123.
    >> Share

  109. YOSHII I, Sawada N, Chijiwa T
    Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 11. pii: 10.1007/s00296-022-05124.
    >> Share

  110. RODERE M, Pereira B, Soubrier M, Fayet F, et al
    Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 7. pii: 10.1007/s00296-022-05090.
    >> Share

  111. YOSHIMURA M, Fujieda Y, Sugawara M, Kono M, et al
    Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study.
    Rheumatol Int. 2022 Apr 6. pii: 10.1007/s00296-022-05121.
    >> Share

  112. JEON YH, Lim DH, Choi SW, Choi SJ, et al
    A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
    Rheumatol Int. 2022;42:743-748.
    >> Share

  113. ZHANG X, Yang Q, Yu H, Yin F, et al
    Bibliometric analysis of the global literature productivity of adult-onset Still's disease (2011-2020).
    Rheumatol Int. 2022;42:707-716.
    >> Share

    March 2022
  114. SKACELOVA M, Nekvindova L, Mann H, Zavada J, et al
    The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.
    Rheumatol Int. 2022 Mar 26. pii: 10.1007/s00296-021-05072.
    >> Share

  115. NAKAYAMA Y, Watanabe R, Murakami K, Murata K, et al
    Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
    Rheumatol Int. 2022 Mar 10. pii: 10.1007/s00296-021-05086.
    >> Share

  116. KABEERDOSS J, Sandhya P, Kurien BT, Scofield RH, et al
    In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
    Rheumatol Int. 2022;42:545-551.
    >> Share

    February 2022
  117. SKRZYPKOWSKA M, Stasiak M, Sakowska J, Chmiel J, et al
    Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.
    Rheumatol Int. 2022 Feb 18. pii: 10.1007/s00296-022-05103.
    >> Share

  118. SWAIN N, Tripathy A, Padhan P, Raghav SK, et al
    Toll-like receptor-7 activation in CD8+ T cells modulates inflammatory mediators in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Feb 10. pii: 10.1007/s00296-021-05050.
    >> Share

  119. QIN L, Zhang Y, Yang X, Luo Q, et al
    Cardiac involvement in primary Sjgren's syndrome.
    Rheumatol Int. 2022;42:179-189.
    >> Share

    January 2022
  120. WILK M, Losinska K, Pripp AH, Korkosz M, et al
    Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
    Rheumatol Int. 2022 Jan 31. pii: 10.1007/s00296-021-05070.
    >> Share

  121. PSALTIS D, Settas L, Georgiadis A, Koukli E, et al
    The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study.
    Rheumatol Int. 2022 Jan 29. pii: 10.1007/s00296-021-05073.
    >> Share

  122. HASAN AA, Reimann F, Veeger NJGM, Bergstra SA, et al
    Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry.
    Rheumatol Int. 2022 Jan 27. pii: 10.1007/s00296-021-05060.
    >> Share

  123. KOSTURKOVA MB, Mihaylova GM, Shivacheva TK, Radanova MA, et al
    Association of C1q gene cluster variants with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2022 Jan 13. pii: 10.1007/s00296-022-05089.
    >> Share

  124. KONSTANTONIS G, Singh KV, Sfikakis PP, Jamthikar AD, et al
    Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients.
    Rheumatol Int. 2022 Jan 11. pii: 10.1007/s00296-021-05062.
    >> Share

  125. VIDEM V, Hoff M, Liff MH
    Use of the Behavioral Regulation in Exercise Questionnaire-2 to assess motivation for physical activity in persons with rheumatoid arthritis: an observational study.
    Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05079.
    >> Share

  126. LAROCHE M, Degboe Y, Constantin A
    Sjogren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study.
    Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05074.
    >> Share

  127. TAYLAN A
    Rituximab therapy in pericarditis associated with rheumatoid arthritis.
    Rheumatol Int. 2022 Jan 5. pii: 10.1007/s00296-021-05080.
    >> Share

  128. CHEN X, Hu QY, Wang M, Jia J, et al
    Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
    Rheumatol Int. 2022;42:149-157.
    >> Share

    December 2021
  129. FRANKOWSKI M, Swierkot J, Gomulkiewicz M, Korman L, et al
    Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Rheumatol Int. 2021 Dec 6. pii: 10.1007/s00296-021-05059.
    >> Share

  130. BAICUS C
    The stratification of primary Sjogren's syndrome: is it really solving the problem?
    Rheumatol Int. 2021;41:2241.
    >> Share

    November 2021
  131. BALCHIN C, Tan AL, Wilson OJ, McKenna J, et al
    Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study.
    Rheumatol Int. 2021 Nov 30. pii: 10.1007/s00296-021-05054.
    >> Share

  132. ROMERA BAURES M, Seoane-Mato D, Alegre-Sancho JJ, Leon L, et al
    Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain.
    Rheumatol Int. 2021 Nov 16. pii: 10.1007/s00296-021-05043.
    >> Share

  133. SERBAN A, Mihai A, Dima A, Balaban DV, et al
    The impact of the COVID-19 pandemic on patients with primary Sjogren syndrome.
    Rheumatol Int. 2021;41:1933-1940.
    >> Share

  134. DARDER A, Losada Lopez I, Gomez-Bellvert C, Rodriguez A, et al
    Pulmonary nodular lymphoid hyperplasia and Sjogren's syndrome: a case report and literature review.
    Rheumatol Int. 2021;41:2041-2044.
    >> Share

  135. PRIORI R, Giardina F, Izzo R, Gattamelata A, et al
    Resilience in women with primary Sjogren's syndrome.
    Rheumatol Int. 2021;41:1987-1994.
    >> Share

    October 2021
  136. DE COCK D, Buckinx E, Pazmino S, Bertrand D, et al
    Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study.
    Rheumatol Int. 2021 Oct 23. pii: 10.1007/s00296-021-05020.
    >> Share

  137. WOLKORTE R, Heesink L, Kip MMA, Koffijberg H, et al
    Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device.
    Rheumatol Int. 2021 Oct 21. pii: 10.1007/s00296-021-05026.
    >> Share

  138. MORALES-ETCHEGARAY I, Garcia-Carrasco M, Munguia-Realpozo P, Mendoza-Pinto C, et al
    Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.
    Rheumatol Int. 2021 Oct 5. pii: 10.1007/s00296-021-05013.
    >> Share

  139. USKUDAR CANSU D, Uskudar Teke H, Korkmaz C
    Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.
    Rheumatol Int. 2021;41:1803-1810.
    >> Share

  140. MITTAL GK, Mittal S, Kaur H, Stephen SR, et al
    Anti-Sjogren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjogren's syndrome waiting to be unveiled? A case series and review of literature.
    Rheumatol Int. 2021;41:1855-1866.
    >> Share

    September 2021
  141. BELANI PJ, Kavadichanda CG, Negi VS
    Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.
    Rheumatol Int. 2021 Sep 29. pii: 10.1007/s00296-021-04994.
    >> Share

  142. MELIKOGLU MA, Ataman S, Bodur H, Cay HF, et al
    Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
    Rheumatol Int. 2021 Sep 24. pii: 10.1007/s00296-021-04992.
    >> Share

  143. ALMUTAIRI K, Nossent J, Preen DB, Keen H, et al
    The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients.
    Rheumatol Int. 2021 Sep 18. pii: 10.1007/s00296-021-04985.
    >> Share

  144. NAFFAA ME, Hassan F, Golan-Cohen A, Merzon E, et al
    Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study.
    Rheumatol Int. 2021 Sep 16. pii: 10.1007/s00296-021-04989.
    >> Share

  145. BARTELS LE, Ammitzboll C, Andersen JB, Vils SR, et al
    Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Rheumatol Int. 2021 Sep 2. pii: 10.1007/s00296-021-04972.
    >> Share

  146. COLLINS A, Lendrem D, Wason J, Tarn J, et al
    Revisiting the JOQUER trial: stratification of primary Sjogren's syndrome and the clinical and interferon response to hydroxychloroquine.
    Rheumatol Int. 2021;41:1593-1600.
    >> Share

  147. GEHIN JE, Klaasen RA, Norli ES, Warren DJ, et al
    Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
    Rheumatol Int. 2021;41:1657-1665.
    >> Share

    August 2021
  148. GONZALEZ DA, Bianchi ML, Salgado PA, Armada M, et al
    Disease activity and subcutaneous nodules are associated to severe periodontitis in patients with rheumatoid arthritis.
    Rheumatol Int. 2021 Aug 22. pii: 10.1007/s00296-021-04974.
    >> Share

  149. ZHAO SS, Nikiphorou E, Young A, Kiely PDW, et al
    Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status-results from the early rheumatoid arthritis study.
    Rheumatol Int. 2021 Aug 16. pii: 10.1007/s00296-021-04931.
    >> Share

  150. MACIVER A, Hollinger H, Carolan C
    Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2021;41:1399-1418.
    >> Share

    July 2021
  151. SOBEJANA M, van den Hoek J, Metsios GS, Kitas GD, et al
    Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study.
    Rheumatol Int. 2021 Jul 31. pii: 10.1007/s00296-021-04903.
    >> Share

  152. ZURA N, Vukorepa M, Jurak I, Peric P, et al
    Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?
    Rheumatol Int. 2021 Jul 28. pii: 10.1007/s00296-021-04959.
    >> Share

  153. BARIK RR, Bhatt LK
    Emerging epigenetic targets in rheumatoid arthritis.
    Rheumatol Int. 2021 Jul 26. pii: 10.1007/s00296-021-04951.
    >> Share

  154. JOHNSTONE G, Treharne GJ, Fletcher BD, Lamar RSM, et al
    Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
    Rheumatol Int. 2021 Jul 23. pii: 10.1007/s00296-021-04952.
    >> Share

  155. MULLER K, Kuipers JG, Weis J, Fischer I, et al
    Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies.
    Rheumatol Int. 2021 Jul 16. pii: 10.1007/s00296-021-04948.
    >> Share

  156. HONNE K, Bando M, Mieno MN, Iwamoto M, et al
    Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
    Rheumatol Int. 2021 Jul 12. pii: 10.1007/s00296-021-04934.
    >> Share

  157. NAKAJIMA T, Watanabe R, Hashimoto M, Murata K, et al
    Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jul 9. pii: 10.1007/s00296-021-04944.
    >> Share

  158. YAGIZ B, Coskun BN, Pehlivan Y, Dalkilic E, et al
    In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
    Rheumatol Int. 2021 Jul 5. pii: 10.1007/s00296-021-04939.
    >> Share

  159. CHEVALLARD M, Belloli L, Ughi N, Adinolfi A, et al
    Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.
    Rheumatol Int. 2021;41:1253-1261.
    >> Share

  160. MULLER R
    Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.
    Rheumatol Int. 2021;41:1189-1202.
    >> Share

    June 2021
  161. OULKADI L, Rostom S, Hmamouchi I, El Hassani Sbai S, et al
    Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.
    Rheumatol Int. 2021 Jun 26. pii: 10.1007/s00296-021-04929.
    >> Share

  162. GOMEZ-GALICIA DL, Aguilar-Castillo J, Garcia-Garcia C, Moctezuma-Rios JF, et al
    Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jun 19. pii: 10.1007/s00296-021-04921.
    >> Share

  163. TANAKA K, Kimura E, Oryoji K, Mizuki SI, et al
    Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
    Rheumatol Int. 2021 Jun 6. pii: 10.1007/s00296-021-04889.
    >> Share

  164. SEBASTIAN A, Woytala P, Madej M, Proc K, et al
    Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjogren's syndrome?
    Rheumatol Int. 2021;41:1125-1131.
    >> Share

  165. WADE SD, Kyttaris VC
    Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
    Rheumatol Int. 2021;41:1115-1124.
    >> Share

    May 2021
  166. FAYET F, Pereira B, Fan A, Rodere M, et al
    Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study.
    Rheumatol Int. 2021 May 29. pii: 10.1007/s00296-021-04893.
    >> Share

  167. SOYSAL E, Ulutas F, Tepeli E, Kaymaz S, et al
    IL-23R gene polymorphisms in rheumatoid arthritis.
    Rheumatol Int. 2021 May 12. pii: 10.1007/s00296-021-04881.
    >> Share

  168. BHATIA A, Kc M, Gupta L
    Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions.
    Rheumatol Int. 2021;41:843-850.
    >> Share

  169. MIGKOS MP, Kaltsonoudis E, Pelechas E, Drossou V, et al
    Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
    Rheumatol Int. 2021;41:903-909.
    >> Share

  170. HEGEMAN MC, Schoemaker-Delsing JA, Luttikholt JTM, Vonkeman HE, et al
    Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.
    Rheumatol Int. 2021;41:973-979.
    >> Share

  171. MANOJ M, Sahoo RR, Singh A, Hazarika K, et al
    Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Rheumatol Int. 2021;41:929-937.
    >> Share

    April 2021
  172. KAESTNER S, Wolff HJ, Braeuer R, Kaestner P, et al
    Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis.
    Rheumatol Int. 2021 Apr 29. pii: 10.1007/s00296-021-04871.
    >> Share

  173. MAEDA Y, Hirano T, Ebina K, Hara R, et al
    Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
    Rheumatol Int. 2021 Apr 26. pii: 10.1007/s00296-021-04862.
    >> Share

  174. TONGA E, Williamson E, Srikesavan C, Ozen T, et al
    A hand exercise mobile app for people with rheumatoid arthritis in Turkey: design, development and usability study.
    Rheumatol Int. 2021 Apr 18. pii: 10.1007/s00296-021-04860.
    >> Share

  175. LU H, Yao Y, Yang J, Zhang H, et al
    Microbiome-miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities.
    Rheumatol Int. 2021 Apr 15. pii: 10.1007/s00296-021-04798.
    >> Share

  176. CHELLAMUTHU G, Muthu S, Khanna M, Khanna V, et al
    "Platelet-rich plasma holds promise in management of rheumatoid arthritis"-systematic review.
    Rheumatol Int. 2021 Apr 8. pii: 10.1007/s00296-021-04849.
    >> Share

  177. ELZORKANY B, Mokbel A, Gamal SM, Hmamouchi I, et al
    Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort.
    Rheumatol Int. 2021;41:699-705.
    >> Share

  178. DEY M, Zhao SS
    Google search data as a novel adjunct to patient and public involvement in rheumatology research.
    Rheumatol Int. 2021;41:771-779.
    >> Share

  179. AKYOL A, Kocyigit BF
    Publication activity in the field of Sjogren's syndrome: a ten-year Web of Science based analysis.
    Rheumatol Int. 2021;41:763-769.
    >> Share

    March 2021
  180. MASLINSKA M, Manczak M, Kwiatkowska B, Ramsperger V, et al
    IgA immunoglobulin isotype of rheumatoid factor in primary Sjogren's syndrome.
    Rheumatol Int. 2021;41:643-649.
    >> Share

    January 2021
  181. ANGELOPOULOU F, Bogdanos D, Dimitroulas T, Sakkas L, et al
    Immune checkpoint inhibitor-induced musculoskeletal manifestations.
    Rheumatol Int. 2021;41:33-42.
    >> Share

    July 2020
  182. ELGHAWY AA, Skopis M, Davis J, Bag-Ozbek A, et al
    Angiostrongyliasis infection masquerading as granulomatosis with polyangiitis: a case-based review.
    Rheumatol Int. 2020;40:1171-1176.
    >> Share

  183. LI R, Wan Q, Chen P, Mao S, et al
    Tocilizumab treatment in Felty's syndrome.
    Rheumatol Int. 2020;40:1143-1149.
    >> Share

  184. LEE SB, Choi H, Kim MK, Jung SM, et al
    Can antineutrophil cytoplasmic antibody positivity at diagnosis predict the poor outcomes of Sjogren's syndrome?
    Rheumatol Int. 2020;40:1063-1070.
    >> Share

    May 2020
  185. PARK EH, Lee EY, Shin K, Kim HA, et al
    Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
    Rheumatol Int. 2020;40:791-798.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016